Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.

Gupta NC, Maloof J, Gunel E.

J Nucl Med. 1996 Jun;37(6):943-8.

2.

Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.

Kim SC, Machac J, Krynyckyi BR, Knesaurek K, Krellenstein D, Schultz B, Gribetz A, DePalo L, Teirstein A, Kim CK.

Ann Nucl Med. 2008 Apr;22(3):165-70. doi: 10.1007/s12149-007-0112-1. Epub 2008 May 23. Erratum in: Ann Nucl Med. 2010 Apr;24(3):231. Kim, Suk C [corrected to Kim, Suk Chul].

PMID:
18498030
3.

Differentiation of radiographically indeterminate solitary pulmonary nodules with.

Hung GU, Shiau YC, Tsai SC, Ho YJ, Kao CH, Yen RF.

Jpn J Clin Oncol. 2001 Feb;31(2):51-4.

4.

Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography.

Hagberg RC, Segall GM, Stark P, Burdon TA, Pompili MF.

Eur J Cardiothorac Surg. 1997 Jul;12(1):92-7.

PMID:
9262087
5.

Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.

Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K.

Chest. 1997 Aug;112(2):416-22.

PMID:
9266877
6.

The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer.

Kagna O, Solomonov A, Keidar Z, Bar-Shalom R, Fruchter O, Yigla M, Israel O, Guralnik L.

Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):997-1004. doi: 10.1007/s00259-009-1061-9. Epub 2009 Feb 5.

PMID:
19194704
7.

Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.

Lee ST, Berlangieri SU, Poon AM, Mitchell P, Pathmaraj K, Tabone K, Byrne AJ, O'Keefe GJ, Knight SR, Clarke CP, Scott AM.

Intern Med J. 2007 Nov;37(11):753-9. Epub 2007 May 21.

PMID:
17517082
8.

[Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].

Martins Rde C, Almeida SA, Siciliano AA, Landesmann MC, Silva FB, Franco CA, Fonseca LM.

J Bras Pneumol. 2008 Jul;34(7):473-80. Portuguese.

9.

Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.

Christensen JA, Nathan MA, Mullan BP, Hartman TE, Swensen SJ, Lowe VJ.

AJR Am J Roentgenol. 2006 Nov;187(5):1361-7.

PMID:
17056930
10.

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Avril N, Dose J, Jänicke F, Ziegler S, Römer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M.

J Natl Cancer Inst. 1996 Sep 4;88(17):1204-9.

11.

Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.

Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Momose M, Nagai A, Ohnuki T, Nishikawa T, Kusakabe K.

J Nucl Med. 2006 Mar;47(3):426-31.

12.

The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.

Hsieh HJ, Lin SH, Lin KH, Lee CY, Chang CP, Wang SJ.

Ann Nucl Med. 2008 Jul;22(6):533-8. doi: 10.1007/s12149-007-0142-8. Epub 2008 Aug 1.

PMID:
18670862
13.

PET in lung cancer.

Coleman RE.

J Nucl Med. 1999 May;40(5):814-20. Review.

14.

Positron emission tomography of incidentally detected small pulmonary nodules.

Fischer BM, Mortensen J, Dirksen A, Eigtved A, Højgaard L.

Nucl Med Commun. 2004 Jan;25(1):3-9.

PMID:
15061259
15.

Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

Gupta NC, Frank AR, Dewan NA, Redepenning LS, Rothberg ML, Mailliard JA, Phalen JJ, Sunderland JJ, Frick MP.

Radiology. 1992 Aug;184(2):441-4.

PMID:
1620844
16.

Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.

Halley A, Hugentobler A, Icard P, Porret E, Sobrio F, Lerochais JP, Bouvard G, Zalcman G, Agostini D.

Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1026-32. Epub 2005 May 5.

PMID:
15877227
17.

Strategy and cost in investigating solitary pulmonary nodules.

Gould MK, Lillington GA.

Thorax. 1998 Aug;53 Suppl 2:S32-7. Review.

18.

Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.

Chun EJ, Lee HJ, Kang WJ, Kim KG, Goo JM, Park CM, Lee CH.

Lung Cancer. 2009 Aug;65(2):180-6. doi: 10.1016/j.lungcan.2008.11.015. Epub 2009 Jan 19.

PMID:
19155090
19.

Risk stratification of solitary pulmonary nodules by means of PET using (18)F-fluorodeoxyglucose and SUV quantification.

Grgic A, Yüksel Y, Gröschel A, Schäfers HJ, Sybrecht GW, Kirsch CM, Hellwig D.

Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1087-94. doi: 10.1007/s00259-010-1387-3. Epub 2010 Feb 6.

PMID:
20140611
20.

Improvement in sensitivity with delayed imaging of pulmonary lesions with FDG-PET.

Núñez R, Kalapparambath A, Varela J.

Rev Esp Med Nucl. 2007 Jul-Aug;26(4):196-207.

Items per page

Supplemental Content

Write to the Help Desk